McKesson Free Cash Flow 2012-2026 | MCK
McKesson annual/quarterly free cash flow history and growth rate from 2012 to 2026. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- McKesson free cash flow for the quarter ending March 31, 2026 was 0.00, a year-over-year.
- McKesson free cash flow for the twelve months ending March 31, 2026 was , a year-over-year.
- McKesson annual free cash flow for 2025 was $5.226B, a 44.09% increase from 2024.
- McKesson annual free cash flow for 2024 was $3.627B, a 21.17% decline from 2023.
- McKesson annual free cash flow for 2023 was $4.601B, a 18% increase from 2022.
| McKesson Annual Free Cash Flow | |
|---|---|
| 2025 | 5,226.00 |
| 2024 | 3,627.00 |
| 2023 | 4,601.00 |
| 2022 | 3,899.00 |
| 2021 | 3,901.00 |
| 2020 | 3,868.00 |
| 2019 | 3,479.00 |
| 2018 | 3,765.00 |
| 2017 | 4,182.00 |
| 2016 | 2,995.00 |
| 2015 | 2,567.00 |
| 2014 | 2,717.00 |
| 2013 | 2,083.00 |
| 2012 | 2,552.00 |
| McKesson Quarterly Free Cash Flow | |
|---|---|
| 2025-12-31 | |
| 2025-09-30 | 1,117.00 |
| 2025-06-30 | -1,107.00 |
| 2025-03-31 | 5,226.00 |
| 2024-12-31 | -2,244.00 |
| 2024-09-30 | 335.00 |
| 2024-06-30 | -1,547.00 |
| 2024-03-31 | 3,627.00 |
| 2023-12-31 | -251.00 |
| 2023-09-30 | -351.00 |
| 2023-06-30 | -1,176.00 |
| 2023-03-31 | 4,601.00 |
| 2022-12-31 | 1,458.00 |
| 2022-09-30 | -56.00 |
| 2022-06-30 | -1,041.00 |
| 2022-03-31 | 3,899.00 |
| 2021-12-31 | 1,167.00 |
| 2021-09-30 | -109.00 |
| 2021-06-30 | -1,781.00 |
| 2021-03-31 | 3,901.00 |
| 2020-12-31 | 745.00 |
| 2020-09-30 | -306.00 |
| 2020-06-30 | -1,179.00 |
| 2020-03-31 | 3,868.00 |
| 2019-12-31 | -618.00 |
| 2019-09-30 | -343.00 |
| 2019-06-30 | -162.00 |
| 2019-03-31 | 3,479.00 |
| 2018-12-31 | -264.00 |
| 2018-09-30 | 70.00 |
| 2018-06-30 | -1,206.00 |
| 2018-03-31 | 3,765.00 |
| 2017-12-31 | 929.00 |
| 2017-09-30 | 1,084.00 |
| 2017-06-30 | 623.00 |
| 2017-03-31 | 4,182.00 |
| 2016-12-31 | 2,940.00 |
| 2016-09-30 | 2,688.00 |
| 2016-06-30 | 1,745.00 |
| 2016-03-31 | 2,995.00 |
| 2015-12-31 | 353.00 |
| 2015-09-30 | 977.00 |
| 2015-06-30 | 334.00 |
| 2015-03-31 | 2,567.00 |
| 2014-12-31 | 830.00 |
| 2014-09-30 | -105.00 |
| 2014-06-30 | 66.00 |
| 2014-03-31 | 2,717.00 |
| 2013-12-31 | 173.00 |
| 2013-09-30 | 614.00 |
| 2013-06-30 | 615.00 |
| 2013-03-31 | 2,083.00 |
| 2012-12-31 | 20.00 |
| 2012-09-30 | 301.00 |
| 2012-06-30 | -630.00 |
| 2012-03-31 | 2,552.00 |
| 2011-12-31 | 1,409.00 |
| 2011-09-30 | 1,168.00 |
| 2011-06-30 | 217.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $106.025B | $359.051B |
| McKesson Corporation distributes pharmaceuticals, medical-surgical supplies and health and beauty care products principally in North America. The Company also develops, implements and supports software which facilitates the integration of data throughout the health enterprise. McKesson Corporation is based in IRVING, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |